Search results for "Review article"

showing 10 items of 426 documents

Suggestions for lung function testing in the context of COVID-19

2021

The 2019 coronavirus disease (COVID-19) pandemic is currently a challenge worldwide. Due to the characteristics of lung function tests, the risk of cross infection may be high between health care workers and patients. The role of lung function testing is well defined for the diagnosis of various diseases and conditions. Lung function tests are also indispensable in evaluating the response to medical treatment, in monitoring patient respiratory and systemic pathologies, and in evaluating preoperative risk in cardiothoracic and major abdominal surgeries. However, lung function testing represents a potential route for COVID-19 transmission, due to the aerosol generated during the procedures an…

Pulmonary and Respiratory Medicinemedicine.medical_specialtywarningsCoronavirus disease 2019 (COVID-19)Context (language use)DiseaseReview ArticleSettore MED/10 - Malattie Dell'Apparato RespiratorioPulmonary function testing03 medical and health sciences0302 clinical medicinePandemicHealth careMedicine030212 general & internal medicineIntensive care medicineLung functionbusiness.industryTransmission (medicine)COVID-19COVID-19; Indications; Lung function testing; warningsrespiratory systemLung function testing030228 respiratory systemIndications Lung function testing warnings COVID-19Indicationsbusiness
researchProduct

Urinary incontinence and quality of life: a systematic review and meta-analysis

2021

AbstractBackgroundUrinary incontinence (UI) and low quality of life (QoL) are two common conditions. Some recent literature proposed that these two entities can be associated. However, no attempt was made to collate this literature. Therefore, the aim of this study was to conduct a systematic review and meta-analysis of existing data to estimate the strength of the association between UI and QoL.MethodsAn electronic search of major databases up to 18th April 2020 was carried out. Meta-analysis of cross-sectional and case–control studies comparing mean values in QoL between patients with UI and controls was performed, reporting random-effects standardized mean differences (SMDs) ± 95% confid…

Quality of lifeAgingmedicine.medical_specialty030232 urology & nephrologyUrinary incontinenceReview Article03 medical and health sciences0302 clinical medicineQuality of lifeMedicineHumans030212 general & internal medicineMeta-analysis; Quality of life; Urinary incontinence; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Quality of Life; Urinary Incontinencebusiness.industryGeriatrics gerontologyMean ageQuality of life Urinary incontinence Meta-analysisConfidence intervalMeta-analysisCross-Sectional StudiesUrinary IncontinenceMeta-analysisCase-Control StudiesPhysical therapyFemaleGeriatrics and Gerontologymedicine.symptombusiness
researchProduct

AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine.

2019

International audience; AGuIX® are sub-5 nm nanoparticles made of a polysiloxane matrix and gadolinium chelates. This nanoparticle has been recently accepted in clinical trials in association with radiotherapy. This review will summarize the principal preclinical results that have led to first in man administration. No evidence of toxicity has been observed during regulatory toxicity tests on two animal species (rodents and monkeys). Biodistributions on different animal models have shown passive uptake in tumours due to enhanced permeability and retention effect combined with renal elimination of the nanoparticles after intravenous administration. High radiosensitizing effect has been obser…

Radiation-Sensitizing AgentsGadoliniummedicine.medical_treatmentGadolinium02 engineering and technologyReview ArticlePharmacologyTheranostic NanomedicineMice0302 clinical medicineMelanomaBrain NeoplasmsMelanomaGeneral Medicine[CHIM.MATE]Chemical Sciences/Material chemistry[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences021001 nanoscience & nanotechnology3. Good health[SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciencesNuclear Medicine & Medical ImagingRadiology Nuclear Medicine and imagingHead and Neck Neoplasms030220 oncology & carcinogenesisToxicity/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being[SDV.IB]Life Sciences [q-bio]/Bioengineering0210 nano-technologyClinical Scienceschemistry.chemical_element[SDV.CAN]Life Sciences [q-bio]/CancerEnhanced permeability and retention effect03 medical and health sciences/dk/atira/pure/subjectarea/asjc/2700/2741SDG 3 - Good Health and Well-being[SDV.CAN] Life Sciences [q-bio]/CancerIn vivo[CHIM.ANAL]Chemical Sciences/Analytical chemistrymedicineAnimalsHumansRadiology Nuclear Medicine and imaging[SDV.IB] Life Sciences [q-bio]/Bioengineeringbusiness.industryCancermedicine.diseaseRadiation therapyClinical trialchemistryNanoparticlesbusinessForecasting
researchProduct

The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy

2014

International audience; A new efficient type of gadolinium-based theranostic agent (AGuIX) has recently been developed for magnetic resonance imaging (MRI)-guided radiotherapy. These new particles consist of a polysiloxane network surrounded by a number of gadolinium chelates, usually 10. Due to their small size (<5 nm), AGuIX typically exhibit biodistributions that are almost ideal for diagnostic and therapeutic purposes. For example, while a significant proportion of these particles accumulate in tumours, the remainder is rapidly eliminated by the renal route. In addition, these particles present no evidence of toxicity, in the absence of irradiation with up to 10 times the planned dose f…

Radiation-Sensitizing Agentsmedicine.medical_treatmentGadoliniumContrast MediaGadoliniumReview Article02 engineering and technologyQUANTUM DOTSIonizing radiation[ SDV.CAN ] Life Sciences [q-bio]/CancerMicechemistry.chemical_compound0302 clinical medicineNuclear magnetic resonanceNeoplasmsIN-VIVOmedicine.diagnostic_testNEUTRON-CAPTURE THERAPYGeneral Medicine021001 nanoscience & nanotechnologyMagnetic Resonance Imaging3. Good health030220 oncology & carcinogenesis/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being0210 nano-technologyMRIMaterials scienceRadiotherapy and OncologySiloxanesMOTEXAFIN GADOLINIUMchemistry.chemical_element[SDV.CAN]Life Sciences [q-bio]/Cancer03 medical and health sciences[SDV.CAN] Life Sciences [q-bio]/CancerSDG 3 - Good Health and Well-beingIn vivoRADIATION-THERAPYmedicineAnimalsHumansBREAST-CANCERRadiology Nuclear Medicine and imagingIrradiationbusiness.industryMagnetic resonance imagingModels TheoreticalRadiation therapychemistryMotexafin gadoliniumGOLD NANOPARTICLESNanoparticlesParticleCONTRAST AGENTSIONIZING-RADIATIONNuclear medicinebusiness
researchProduct

Subjective Experience of Episodic Memory and Metacognition: A Neurodevelopmental Approach

2013

Episodic retrieval is characterized by the subjective experience of remembering. This experience enables the co-ordination of memory retrieval processes and can be acted on metacognitively. In successful retrieval, the feeling of remembering may be accompanied by recall of important contextual information. On the other hand, when people fail (or struggle) to retrieve information, other feelings, thoughts and information may come to mind. In this review, we examine the subjective and metacognitive basis of episodic memory function from a neurodevelopmental perspective, looking at recollection paradigms (such as source memory, and the report of recollective experience) and metacognitive parad…

Reconstructive memoryRecallAutobiographical memoryrecollectionneurodevelopmental disordersCognitive NeuroscienceBrain DevelopmentmetamemoryReview Articleepisodic memorylcsh:RC321-571Behavioral NeuroscienceNeuropsychology and Physiological PsychologyRetrospective memoryProspective memoryExplicit memorySemantic memoryPsychologyEpisodic memorylcsh:Neurosciences. Biological psychiatry. NeuropsychiatryCognitive psychologyNeuroscienceFrontiers in Behavioral Neuroscience
researchProduct

Genomic insights into the different layers of gene regulation in yeast.

2011

The model organism Saccharomyces cerevisiae has allowed the development of new functional genomics techniques devoted to the study of transcription in all its stages. With these techniques, it has been possible to find interesting new mechanisms to control gene expression that act at different levels and for different gene sets apart from the known cis-trans regulation in the transcription initiation step. Here we discuss a method developed in our laboratory, Genomic Run-On, and other new methods that have recently appeared with distinct technical features. A comparison between the datasets generated by them provides interesting genomic insights into the different layers of gene regulation …

Regulation of gene expressionlcsh:QH426-470biologyved/biologySaccharomyces cerevisiaeved/biology.organism_classification_rank.speciesComputational biologyReview Articlebiology.organism_classificationBioinformaticsSaccharomycesYeastlcsh:GeneticsTranscription (biology)Gene expressionGeneticsModel organismMolecular BiologyFunctional genomicsGenetics (clinical)Genetics research international
researchProduct

Planning and Analysis of Trials Using a Stepped Wedge Design: Part 26 of a Series on Evaluation of Scientific Publications

2019

Background The stepped-wedge design (SWD) of clinical trials has become very popular in recent years, particularly in health services research. Typically, study participants are randomly allotted in clusters to the different treatment options. Methods The basic principles of the stepped wedge design and related statistical techniques are described here on the basis of pertinent publications retrieved by a selective search in PubMed and in the CIS statistical literature database. Results In a typical SWD trial, the intervention is begun at a time point that varies from cluster to cluster. Until this time point is reached, all participants in the cluster belong to the control arm of the trial…

Research designClinical Trials as Topic030505 public healthRandomizationbusiness.industryHealth services researchMEDLINEReview ArticleGeneral Medicine01 natural sciencesClinical trialNormal distribution010104 statistics & probability03 medical and health sciencesResearch DesignIntervention (counseling)StatisticsCluster AnalysisMedicine0101 mathematicsTime point0305 other medical sciencebusinessDeutsches Ärzteblatt international
researchProduct

Cluster-Randomized Studies.

2018

Background Cluster-randomized trials (CRT) are needed to compare interventions that are allocated to entire groups of subjects, rather than to individuals. Publications about CRT have become steadily more common over the past decade. Readers of such publications should be able to categorize and interpret the findings of CRT correctly while considering the methodological requirements applicable to this type of study. Methods This review is based on a selection of pertinent literature and on the authors' expertise. CRT-specific methodological aspects of the planning, performance, and interpretation of studies are discussed. Results Readers of publications on CRT should check whether due consi…

Research designFuture studiesBiomedical Researchbusiness.industryMEDLINEPsychological interventionConsolidated Standards of Reporting TrialsGuidelines as TopicGeneral MedicineReview Article01 natural sciences010104 statistics & probability03 medical and health sciences0302 clinical medicineCategorizationResearch DesignSelection (linguistics)MedicineCluster AnalysisHumans030212 general & internal medicine0101 mathematicsbusinessCognitive psychologyRandomized Controlled Trials as TopicDeutsches Arzteblatt international
researchProduct

DNA damage-induced phosphatase Wip1 in regulation of hematopoiesis, immune system and inflammation.

2016

PP2C serine–threonine phosphatase, Wip1, is an important regulator of stress response. Wip1 controls a number of critical cellular functions: proliferation, cell cycle arrest, senescence and programmed cell death, apoptosis or autophagy. Ppm1d, the gene encoding Wip1 phosphatase, is expressed in hematopoietic progenitors, stem cells, neutrophils, macrophages B and T lymphocytes in bone marrow and peripheral blood. The Wip1−/− mice display immunodeficiency, abnormal lymphoid histopathology in thymus and spleen, defects in B- and T-cell differentiation, as well as susceptibility to viral infection. At the same time, Wip1 knockout mice exhibit pro-inflammatory phenotype in skin and intestine i…

Review ArticleCell death discovery
researchProduct

Functional Hallmarks of GABAergic Synapse Maturation and the Diverse Roles of Neurotrophins

2011

Functional impairment of the adult brain can result from deficits in the ontogeny of GABAergic synaptic transmission. Gene defects underlying autism spectrum disorders, Rett’s syndrome or some forms of epilepsy, but also a diverse set of syndromes accompanying perinatal trauma, hormonal imbalances, intake of sleep-inducing or mood-improving drugs or, quite common, alcohol intake during pregnancy can alter GABA signaling early in life. The search for therapeutically relevant endogenous molecules or exogenous compounds able to alleviate the consequences of dysfunction of GABAergic transmission in the embryonic or postnatal brain requires a clear understanding of its site- and state-dependent …

Review ArticleBiologyNeurotransmissionInhibitory postsynaptic potentialgamma-Aminobutyric acidlcsh:RC321-571tonic inhibitionCellular and Molecular NeurosciencePostsynaptic potentialPresynaptic functionmedicinelcsh:Neurosciences. Biological psychiatry. Neuropsychiatryquantal analysisNGFSynaptic pharmacologyexcitatory–inhibitory balanceGABAergic synaptic transmissionBDNFbiology.proteinGABAergicsynapse developmentNeuroscienceSynapse maturationNeuroscienceNeurotrophinmedicine.drugFrontiers in Cellular Neuroscience
researchProduct